Compare the Efficacy and Safety of KH607 Tablets Versus Vortioxetine Hydrobromide Tablets in Adult Patients With Major Depressive Disorder

NCT07741331 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

326

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder (MDD)

Interventions

DRUG: KH607 tablets
DRUG: Vortioxetine Hydrobromide Tablets
DRUG: Part B: KH607

Sponsor

Chengdu Kanghong Pharmaceutical Group Co., Ltd.